SKI Market

A+| A| A-|

Indian Indices

Sensex

77,017.79 -251.61
( -0.33%)

Global Indices

Nasdaq

48,970.60 -549.68
(-1.11%)

Dow Jones

7,222.65 -28.47
(-0.39%)

Hang Seng

59,594.47 309.55
(0.52%)

Nikkei 225

10,363.93 -14.87
(-0.14%)

Forex

USD-INR

94.82 -0.13
(-0.14%)

EUR-INR

111.15 0.04
(0.04%)

GBP-INR

128.70 0.21
(0.16%)

JPY-INR

0.60 0.00
(0.59%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ambuja Cements Ltd

Industry : Cement - North India

BSE Code

ISIN Demat

Book Value()

500425

INE079A01024

204.8376183

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AMBUJACEM

30.87

110624.06

EPS(TTM)

Face Value()

Div & Yield %

14.42

0.45

Back

ERIS Lifesciences consolidated net profit rises 19.05% in the December 2025 quarter

Feb 13,2026

Net profit of ERIS Lifesciences rose 19.05% to Rs 99.72 crore in the quarter ended December 2025 as against Rs 83.76 crore during the previous quarter ended December 2024. Sales rose 10.91% to Rs 800.89 crore in the quarter ended December 2025 as against Rs 722.12 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	800.89	722.12	11
OPM %	35.16	34.66	-
PBDT	232.93	197.36	18
PBT	162.59	116.36	40
NP	99.72	83.76	19

77,017.79 -251.61 ( -0.33%)

48,970.60 -549.68 (-1.11%)

7,222.65 -28.47 (-0.39%)

59,594.47 309.55 (0.52%)

10,363.93 -14.87 (-0.14%)

94.82 -0.13 (-0.14%)

111.15 0.04 (0.04%)

128.70 0.21 (0.16%)

0.60 0.00 (0.59%)